HIGHLIGHTS
- who: Saul Yedgar et al. from the Department of Biochemistry, The Faculty of Medicine, Hebrew University, Jerusalem, Israel have published the paper: Hemolytic Activity of Nanoparticles as a Marker of Their Hemocompatibility, in the Journal: Micromachines 2022, 2091 of /2022/
- what: As a recommendation the authors propose studying the of nanomaterials under more physiologically relevant conditions in the presence of plasma proteins in the medium and under mechanical stress. This aspect is the focus of the first section of the review .
SUMMARY
Saha et_al found that a linear hemolytic profile with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.